Valuation : China Resources Pharmaceutical Group Limited

Market Cap 28.71B 3.66B 3.16B 2.96B 2.7B 5.09B 350B 5.1B 35.1B 13.7B 177B 13.75B 13.45B 586B P/E 2026 *
5.85x
P/E 2027 * 5.49x
Enterprise Value 85.94B 10.96B 9.45B 8.86B 8.08B 15.23B 1,048B 15.28B 105B 40.99B 529B 41.15B 40.26B 1,754B EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.21x
Free-Float
29.17%
Yield 2026 *
4.39%
Yield 2027 * 4.75%
1 week-6.67%
Current month-6.67%
1 month-6.67%
3 months-0.81%
6 months+2.08%
Current year+2.51%
1 week 0.49
Extreme 0.486
0.52
1 month 0.49
Extreme 0.486
0.55
3 years 0.46
Extreme 0.458
0.8
5 years 0.36
Extreme 0.356
0.9
Manager TitleAgeSince
President 47 26/08/2025
Director of Finance/CFO 54 13/06/2023
Corporate Secretary - 15/12/2025
Director TitleAgeSince
Director/Board Member 59 01/06/2016
Director/Board Member 70 20/06/2016
Chairman 55 29/08/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-6.67%-6.67%-20.97% 3.66B
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.75%-2.68%+24.96%+41.06% 406.59B
Weighted average by Cap. -0.46%-3.46%+38.13%+64.92%

Financials

2026 *2027 *
Net sales 329B 42.01B 36.2B 33.94B 30.98B 58.37B 4,015B 58.55B 403B 157B 2,027B 158B 154B 6,720B 342B 43.6B 37.57B 35.22B 32.15B 60.57B 4,167B 60.76B 418B 163B 2,103B 164B 160B 6,974B
Net income 4.82B 615M 530M 497M 453M 854M 58.74B 857M 5.89B 2.3B 29.65B 2.31B 2.26B 98.33B 5.18B 661M 570M 534M 488M 919M 63.2B 922M 6.34B 2.47B 31.9B 2.48B 2.43B 106B
Net Debt 57.23B 7.3B 6.29B 5.9B 5.38B 10.14B 698B 10.17B 69.97B 27.3B 352B 27.4B 26.81B 1,168B 42.15B 5.38B 4.63B 4.34B 3.96B 7.47B 514B 7.49B 51.53B 20.11B 259B 20.18B 19.74B 860B
Logo China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
Employees
-
Date Price Change
28/08/26 €0.4900 +0.41%
27/08/26 €0.4880 0.00%
26/08/26 €0.4880 -2.40%
25/08/26 €0.5000 -1.96%
24/08/26 €0.5100 -2.86%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
4.570HKD
Average target price
6.553HKD
Spread / Average Target
+43.40%

Quarterly revenue - Rate of surprise